ZLAB
Zai Lab Announces Pricing of Public Offering of American Depositary Shares and Ordinary Shares
Tuesday, April 20, 2021 BiopharmaWatch Research 1 min read Key Takeaway: Zai Lab Announces Pricing of Public Offering of American Depositary Shares and Ordinary Shares
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+60%
120-day peak, hindsight
Typical move
2.2%
average across 15 past catalysts
Cash runway
~28 mo
Low dilution risk
Lead asset
ZL-1310
Phase 3 · Small-cell Lung Cancer
Full Press Release Details
Zai Lab Announces Pricing of Public Offering of American Depositary Shares and Ordinary Shares.